Jan 11, 2021 06:11 PM (GMT+8) · EqualOcean
Fosun Pharmaceutical announced that recently, Chongqing Yaoyou Pharmaceutical Co., Ltd., a holding subsidiary of the company, received the acceptance notice, and its yp01001 capsule for the treatment of advanced solid tumors (liver cancer, gastric cancer, etc.) was accepted by the State Food and Drug Administration for clinical trial registration.